Prestige Consumer Healthcare Inc. (FRA:PBV)

Revenue Breakdown

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016	Mar 31, 2015	Mar 31, 2014	Mar 31, 2013
North American OTC Healthcare Revenue	931.22M	960.01M
International OTC Healthcare Revenue	179.26M	177.75M
Revenue (Total)	1.11B	1.14B

Revenue Breakdown 2

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016	Mar 31, 2015	Mar 31, 2014	Mar 31, 2013
Analgesics Revenue	118.85M	117.70M
Cough & Cold Revenue	102.53M	106.21M
Women's Health Revenue	234.86M	236.83M
Gastrointestinal Revenue	259.85M	255.94M
Eye & Ear Care Revenue	158.89M	183.32M
Dermatologicals Revenue	125.54M	128.95M
Oral Care Revenue	96.64M	95.03M
Other OTC Revenue	13.31M	13.78M
Revenue (Total)	1.11B	1.14B

Gross Profit

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016	Mar 31, 2015	Mar 31, 2014	Mar 31, 2013
North American OTC Healthcare Gross Margin	521.16M	531.14M
International OTC Healthcare Gross Margin	101.81M	103.32M
Gross Profit (Total)	622.97M	634.46M

Adjusted Gross Profit

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016	Mar 31, 2015	Mar 31, 2014	Mar 31, 2013
North American OTC Healthcare Contribution Margin	399.39M	401.71M
International OTC Healthcare Contribution Margin	75.00M	77.03M
Gross Profit (Other)	148.59M	155.72M
Gross Profit (Total)	622.97M	634.46M

Updated Sep 30, 2025. Data Source: Fiscal.ai.